- Home
- QXO vs SNN Comparison
QXO vs SNN Comparison
Compare QXO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QXO
- SNN
- Stock Information
- Founded
- QXO 1988
- SNN 1856
- Country
- QXO United States
- SNN United Kingdom
- Employees
- QXO N/A
- SNN N/A
- Industry
- QXO EDP Services
- SNN Industrial Specialties
- Sector
- QXO Technology
- SNN Health Care
- Exchange
- QXO Nasdaq
- SNN Nasdaq
- Market Cap
- QXO 12.8B
- SNN 13.2B
- IPO Year
- QXO N/A
- SNN 1999
- Fundamental
- Price
- QXO $19.77
- SNN $35.91
- Analyst Decision
- QXO Strong Buy
- SNN Hold
- Analyst Count
- QXO 12
- SNN 3
- Target Price
- QXO $33.64
- SNN $31.50
- AVG Volume (30 Days)
- QXO 8.8M
- SNN 657.7K
- Earning Date
- QXO 11-12-2025
- SNN 10-30-2025
- Dividend Yield
- QXO N/A
- SNN 2.04%
- EPS Growth
- QXO N/A
- SNN 59.91
- EPS
- QXO N/A
- SNN 0.56
- Revenue
- QXO $1,947,673,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- QXO $13,023.98
- SNN $7.75
- Revenue Next Year
- QXO $56.11
- SNN $5.37
- P/E Ratio
- QXO N/A
- SNN $64.30
- Revenue Growth
- QXO 3309.07
- SNN 5.35
- 52 Week Low
- QXO $11.85
- SNN $23.69
- 52 Week High
- QXO $24.69
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- QXO 44.66
- SNN 43.79
- Support Level
- QXO $18.27
- SNN $35.66
- Resistance Level
- QXO $21.14
- SNN $36.48
- Average True Range (ATR)
- QXO 0.72
- SNN 0.41
- MACD
- QXO 0.01
- SNN -0.13
- Stochastic Oscillator
- QXO 41.17
- SNN 37.76
About QXO QXO Inc. Common Stock
QXO Inc is a building products distribution company engaged in the distribution of roofing, waterproofing and complementary building products in North America. It offers a full suite of business applications, including ERP, warehouse management, accounting, CRM, and business intelligence solutions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.